Expired Tender Belgium ICB TOT Ref. 13506729

Contract notice: Antineoplastic Tender in Belgium - 13506729

Tender notice from Belgium, published on 24 May 2017.

Executive Summary

The HOSPILIM VZW has issued a Tender notice for the procurement of a Contract notice: Antineoplastic and immunomodulating agents in the Belgium. This Tender notice was published on 24 May 2017 and is scheduled to close on 30 Jun 2017, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 13506729, while the tender notice number is 197078-2017 and Register on the platform.

Key facts

Summary
Contract notice: Antineoplastic and immunomodulating agents
TOT Ref. No.
13506729
Document Ref. No.
197078-2017
Country
Belgium
Notice type
Tender
Competition
ICB
Publication date
24 May 2017
Bid deadline
30 Jun 2017
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
Antineoplastic and immunomodulating agents
Description: Contract notice: Antineoplastic and immunomodulating agents
Authority Type: Other
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: The most economic tender
CPV code: 33652000, 33652000
CPV Description: Delivery of Infliximab to the working members of HospiLim.
Antineoplastic and immunomodulating agents.
Applicable regulation:
1. Act of 15.6.2006 on public procurement and certain contracts for the acquisition of works, supplies and services, and subsequent amendments. 2. Royal Decree of 15.7.2011 concerning the placement of public procurement classical sectors, and later amendmentWent.
3. Royal Decree of 14.1.2013 laying down the general implementing rules for public procurement and public works concessions, and subsequent amendments. Law of 17.6.2013 on the grounds, information and remedies for public procurement and certain works, supplies and services. The General Rules for the Labor CourtErming (ARAB), Welfare and Codex on Welfare at Work.
6. KB of 3.7.1969 regarding the registration of drugs, and its subsequent side effects.
7. Drugs Act of 25 March 1964.
8. KB of 6 June 1960 concerning the manufacture and distribution of medicinal products and the handling of medicinal products, and its subsequent side effects. Furthermore, all unnamed and applicable standards thatEffects are ten days prior to the date of the tender.
Derogations, additions and comments:
Article 57, paragraph 1 of the Royal Decree of 15.7.2011:
The commitment period will be 90 to 180 calendar days.
Article 25 of the royal Decree of 14.1.2013:
No bail is required, although this is legally required.
Justification: The continuous withdrawals The assignedA minimum competitiveness under this framework agreement justifies the non-application of the guarantee.
Article 20 of the Royal Decree of 15.7.2011:
No price revisions are applied.
Justification: As it is a framework agreement and price is only added in the successive minicompetitions There is no price review applicable to the framework agreement.
ArArticle 5 of the Royal Decree of 14.1.2013 - AUR:
The general implementing rules (AUR) will also apply to individual contracts awarded under the framework agreement, the estimated amount of which remains below 8 500 EUR (excl. VAT).
Note:
The tenderers indicate which parts are confidential.
None.
HospiLim allows the tenderers, an explicitTo honor a declaration of honor in which they are not in one of the exclusions as referred to in Article 61, paragraphs 1 and 2.
This will be the responsibility of the client to: - the candidates eligible for selection when closing the Agreement; - the successful tenderer as the contractor prior to the final award decision.Declaration of honor implies that the tenderer: - has not been convicted of participating in a criminal organization, bribery, fraud or money laundering; - is not in the event of bankruptcy or liquidation; - has not made a bankruptcy declaration or Proceedings of liquidation or judicial reorganization has been against him;
has not been convicted of an offenseWho has been in a professional profession, has not committed a serious mistake; - is in agreement with the payment of social security contributions; - is in agreement with the payment of taxes; - has not been guilty of false Statements in providing such information
Internet address (URL): www.hospilim.be
Directive: Classical Directive (2004/18/EC)

Documents

Tender Notice
Login to view

Similar tenders

Belgium Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: Antineoplastic and immunomodulating agents was 30 Jun 2017. Bidding is closed.

This tender has been issued by HOSPILIM VZW in Belgium.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33652000 - Antineoplastic and immunomodulating agents.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 13506729. The purchaser document reference is 197078-2017.

See the Similar Tenders section on this page or browse other tenders from Belgium.

This tender falls under Materials and Products in Belgium. Suppliers in these sectors can track similar Belgium tenders using CPV-based alerts.